Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen announces publication of data from Phase 3 LAPLACE-2 study of evolocumab
Amgen announces publication of data from Phase 3 LAPLACE-2 study of evolocumab
Amgen announces publication of data from Phase 3 LAPLACE-2 study of evolocumab
Submitted by
admin
on May 13, 2014 - 10:21pm
Source:
The Fly on the Wall
News Tags:
Amgen
evolocumab
Headline:
Amgen announces publication of data from Phase 3 LAPLACE-2 study of evolocumab
Do Not Allow Advertisers to Use My Personal information
